PubMed HealthSearch

PubMed · 7121263

Apolipoprotein E levels in vegetarians.

Abstract

Vegetarians are known to have low lipoprotein lipid and apolipoprotein Al and B levels. Since dietary cholesterol has recently been shown to have important effects on apolipoprotein E (apo E) metabolism, we measured plasma apo E levels in three groups of vegetarians. Group I (n = 36) consumed less than 10 mg cholesterol daily and 42% of calories as fat (P:S ratio 2.6). Group II (n = 10) and Group III (n = 18) consumed 97 and 179 mg cholesterol daily, and 35% of calories as fat (P:S ratios 0.7 and 0.9) respectively. Compared to control values, vegetarian plasma cholesterol and triglyceride levels were decreased by 10%-30% and 30%-55%. Plasma apo E levels were decreased equally in all groups by 35% (2.4 +/- 0.1 mg/dl versus 3.6 +/0 0.1 mg/kl, P less than .001). Plasma apo E levels were increased in parallel with lipid levels in pregnant vegetarians but were not different from non-lactating vegetarians in postpartum lactating women. Decreased apo E levels did not correlate with relative body weight, P:S ratio or intake of fat, carbohydrates or protein. Since all vegetarian diets studied were low cholesterol diets, decreased cholesterol intake may contribute to the low apo E levels. The apparent modification of apo E metabolism by vegetarian diets may be important in mediating effects of lipid lowering diets on atherogenesis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D R Lock, A Varhol, S Grimes, W Patsch, G Schonfeld. 1982. Apolipoprotein E levels in vegetarians.. https://doi.org/10.1016/0026-0495(82)90182-2

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Relevance of body weight to apolipoprotein levels in Australian children.

OBJECTIVES: To assess weight and apolipoprotein profiles in a representative sample of primary school children. PARTICIPANTS AND SETTING: 1543 children (936 girls and 607 boys) aged 6-11 years from schools in the Eastern Sydney Area Health Service region in 1994. METHODS: We measured body mass index (BMI) and capillary blood apolipoprotein (apo) B and A-I levels (the carrier proteins for low and high density lipoprotein cholesterol, respectively) as well as lipoprotein (Lp) (a). We related BMI levels to those documented in the 1985 Australian Council on Health, Physical Education and Recreation (ACHPER) survey of school children. RESULTS: Compared with the ACHPER distribution, BMI was increased in the boys but not in the girls; 16.8% of boys were above the 90th percentile of the ACHPER distribution (P = 0.003) and only 6.5% were below the 10th percentile (P = 0.046). There were 45 boys (7.4%) and 53 girls (5.7%) with BMIs above the 95th percentile who were, by definition, obese. They had highly significant increases in apo B (P = 0.003) and apo B: apo A-I ratio (P = 0.0001) compared with children in the normal BMI range (10th-90th percentiles); and 20% of the population, including the obese group, also had Lp(a) levels greater than 300 mg/L. The results in children aged 10 and 11 years were not different from those of the whole group, consistent with an absence of possible confounding effects due to early puberty or smoking. CONCLUSIONS: There was an increase in weight relative to height in boys aged 6-11 years in eastern Sydney, compared with the 1985 ACHPER survey. In both boys and girls with the highest BMI category, levels of apo B and the apo B: apo A-I ratio were significantly increased. As these apolipoprotein changes are correlated closely with early onset atherogenesis and are correctable, their identification offers prospects for prevention.

Apolipoproteins

Characteristics of ten charge-differing subfractions isolated from human native low-density lipoproteins (LDL). No evidence of peroxidative modifications.

Native plasma low-density lipoproteins (LDL) were fractionated into ten subfractions with increasingly negative charges (LDL-1, the least electronegative, to LDL-10) using an anion-exchange column coupled to a fast protein-liquid chromatography system. Prior to fractionation, contaminating Lp(a) and apo A-I-containing lipoproteins were removed from LDL preparations by immunoaffinity chromatography. No significant difference in thiobarbituric acid-reactive substances, vitamin E or free aminogroup was found among subfractions, and no peptide with a higher molecular weight than apo B was observed on SDS-PAGE. We observed a gradual increase in cholesterol esters and a concomitant decrease in triglycerides from LDL-1 to LDL-7, and a reverse tendency from LDL-8 to LDL-10 (P < 0.01). Free cholesterol increased linearly from LDL-1 to LDL-10 (P < 0.01). LDL-1 to -3 had a homogeneous density profile, while other more electronegative subfractions showed a bimodal distribution with a second, minor peak of slightly higher density. A gradual increase in apolipoprotein C-III content related to LDL electronegativity was observed (P < 0.001). Apolipoprotein E content was also increased in the last two subfractions (P < 0.01). LDL subfractions displayed a similar binding fate on human fibroblasts, with the exception of the most electronegative subfractions [LDL-(9 + 10)], which bound more actively to apo B/E receptors (P < 0.05). This study shows that charge heterogeneity of native LDL is not related to lipid peroxidation or derivatization of free aminogroups of apolipoprotein B. In contrast, the enrichment of LDL in apolipoproteins other than apo B may explain, in part, the difference in their particle charge.

Apolipoproteins

Arachidonic acid binds to apolipoprotein D: implications for the protein's function.

The lipocalin apolipoprotein D (ApoD) is associated in human plasma with lecithin-cholesterol acyl transferase. It has also been found in high concentration in the fluid of gross cystic disease of the mammary gland. Using protein fluorescence quenching, it is shown that ApoD binds arachidonic acid (Ka of 1.6 x 10(8) M-1) and as previously known progesterone (Ka of 2.5 x 10(6) M-1), but neither cholesterol nor any of the other prostanoid molecules examined had measurable affinity. This specific binding of arachidonate, also observable directly, suggests a role for ApoD in the mobilisation of arachidonic acid, and hence prostaglandin synthesis.

Apolipoproteins